Found: 31
Select item for more details and to access through your institution.
FLT3-ITD mutations do not impact the outcome of patients allografted with partial T-cell depleted grafts for AML with normal cytogenetics in first complete remission.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients.
- Published in:
- Medical Mycology, 2021, v. 59, n. 7, p. 701, doi. 10.1093/mmy/myaa106
- By:
- Publication type:
- Article
Hepatitis E Virus Infection Epidemiology in Recipients of Allogeneic Hematopoietic Cell Transplant.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 12, p. 1, doi. 10.1093/ofid/ofad595
- By:
- Publication type:
- Article
Routine Infectious Disease Consultation Prior to an Allogeneic Hematopoietic Cell Transplant.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 12, p. 1, doi. 10.1093/ofid/ofad578
- By:
- Publication type:
- Article
Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress?
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 1, p. 1, doi. 10.1093/ofid/ofab596
- By:
- Publication type:
- Article
Optimal Treatment Duration of Pseudomonas aeruginosa Infections in Allogeneic Hematopoietic Cell Transplant Recipients.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 7, p. 1, doi. 10.1093/ofid/ofaa246
- By:
- Publication type:
- Article
Transfusion-transmitted cytomegalovirus: behaviour of cell-free virus during blood component processing. A study on the safety of labile blood components in Switzerland.
- Published in:
- Blood Transfusion (17232007), 2020, v. 18, n. 6, p. 446, doi. 10.2450/2020.0241-19
- By:
- Publication type:
- Article
Clinical Considerations of Isavuconazole Administration in High-Risk Hematological Patients: A Single-Center 5-Year Experience.
- Published in:
- Mycopathologia, 2021, v. 186, n. 6, p. 775, doi. 10.1007/s11046-021-00583-9
- By:
- Publication type:
- Article
Letermovir Primary Prophylaxis in High-Risk Hematopoietic Cell Transplant Recipients: A Matched Cohort Study.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 372, doi. 10.3390/vaccines9040372
- By:
- Publication type:
- Article
Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell Transplantation.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01034
- By:
- Publication type:
- Article
Human pegivirus-1 replication influences NK cell reconstitution after allogeneic haematopoietic stem cell transplantation.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2022.1060886
- By:
- Publication type:
- Article
T315I clone selection in a Ph+ all patient under low-dose ponatinib maintenance.
- Published in:
- Clinical Case Reports, 2017, v. 5, n. 8, p. 1320, doi. 10.1002/ccr3.1032
- By:
- Publication type:
- Article
Longitudinal Detection of Twenty DNA and RNA Viruses in Allogeneic Hematopoietic Stem Cell Transplant Recipients Plasma.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 4, p. 928, doi. 10.3390/v15040928
- By:
- Publication type:
- Article
Rhinovirus Infections among Hematopoietic Stem Cell Transplant Recipients: A Pre-Transplant Dilemma?
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 2, p. 267, doi. 10.3390/v14020267
- By:
- Publication type:
- Article
Intracellular Pathogen in the Cerebrospinal Fluid of an Allogeneic Hematopoietic Cell Transplant Recipient With Graft-Versus-Host Disease and Brain Lesions.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 11, p. 3005, doi. 10.1093/cid/ciaa235
- By:
- Publication type:
- Article
Very severe immune thrombocytopenia following SARS-CoV-2 vaccination requiring splenectomy: a case report.
- Published in:
- Thrombosis Journal, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12959-022-00404-z
- By:
- Publication type:
- Article
Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high‐risk hematopoietic cell transplant recipients.
- Published in:
- Immunity, Inflammation & Disease, 2021, v. 9, n. 3, p. 771, doi. 10.1002/iid3.431
- By:
- Publication type:
- Article
Immunological Basis of Bone Marrow Failure after Allogeneic Hematopoietic Stem Cell Transplantation.
- Published in:
- Frontiers in Immunology, 2016, p. 1, doi. 10.3389/fimmu.2016.00362
- By:
- Publication type:
- Article
Revisiting Cytomegalovirus Serology in Allogeneic Hematopoietic Cell Transplant Recipients.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 2, p. 423, doi. 10.1093/cid/ciad550
- By:
- Publication type:
- Article
Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997–2021.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 1, p. 1, doi. 10.1002/hon.3241
- By:
- Publication type:
- Article
Real-Life Considerations on Antifungal Treatment Combinations for the Management of Invasive Mold Infections after Allogeneic Cell Transplantation.
- Published in:
- Journal of Fungi, 2021, v. 7, n. 10, p. 1, doi. 10.3390/jof7100811
- By:
- Publication type:
- Article
Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: A 5‐year analysis within the Swiss Transplant Cohort study.
- Published in:
- Transplant Infectious Disease, 2020, v. 22, n. 4, p. 1, doi. 10.1111/tid.13289
- By:
- Publication type:
- Article
Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruption.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1095870
- By:
- Publication type:
- Article
Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation: a case report.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1360275
- By:
- Publication type:
- Article
When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?
- Published in:
- Mycoses, 2022, v. 65, n. 11, p. 1061, doi. 10.1111/myc.13496
- By:
- Publication type:
- Article
Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections.
- Published in:
- Mycoses, 2022, v. 65, n. 2, p. 199, doi. 10.1111/myc.13416
- By:
- Publication type:
- Article
Compartmentalization of a Multidrug-Resistant Cytomegalovirus UL54 Mutant in a Stem Cell Transplant Recipient with Encephalitis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Severe anaphylaxis after chimeric antigen receptor T‐cell injection: a case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma in Switzerland, 20 years of experience: 2001–2020.
- Published in:
- EJHaem, 2023, v. 4, n. 1, p. 262, doi. 10.1002/jha2.629
- By:
- Publication type:
- Article
Allogeneic hematopoietic stem cell transplantation in non‐Hodgkin lymphoma in Switzerland, 30 years of experience: Sooner is better.
- Published in:
- EJHaem, 2023, v. 4, n. 1, p. 258, doi. 10.1002/jha2.614
- By:
- Publication type:
- Article